摘要
Sustained proliferative signaling is a crucial hallmark and therapeutic target in glioblastoma (GBM); however, new intrinsic regulators and their underlying mechanisms remain to be elucidated. In this study, I kappa B kinase interacting protein (IKBIP) was identified to be correlated with the progression of GBM by analysis of The Cancer Genome Atlas (TCGA) data. TCGA database analysis indicated that higher IKBIP expression was associated with high tumor grade and poor prognosis in GBM patients, and these correlations were subsequently validated in clinical samples. IKBIP knockdown induced G1/S arrest by blocking the Cyclin D1/CDK4/CDK6/CDK2 pathway. Our results showed that IKBIP may bind directly to CDK4, a key cell cycle checkpoint protein, and prevent its ubiquitination-mediated degradation in GBM cells. An in vivo study confirmed that IKBIP knockdown strongly suppressed cell proliferation and tumor growth and prolonged survival in a mouse xenograft model established with human GBM cells. In conclusion, IKBIP functions as a novel driver of GBM by binding and stabilizing the CDK4 protein. IKBIP could be a potential therapeutic target in GBM.
学科与关键词
- IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-kappa BGuan Hongyu; Zhang Heng; Cai Junchao; Wu Jueheng; Yuan Jie; Li Jun; Huang Zhengsong; Li Mengfeng*Journal of Pathology, 2011, 223(3): 436-445.被引 20
- TUBA1A licenses APC/C-mediated mitotic progression to drive glioblastoma growth by inhibiting PLK3Wen, Jiaqi; Wang, Qiuke; Zhang, Wenyi; Wang, Weizhang*the and of llh 2019 for、with、to\ of the 、 or the\the、or、of d &、&、希基准, 2023, 597(24): 3072-3086.
- PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1BWang, Ji; Xiao, Zongyu; Li, Peng; Wu, Chunwang; Li, Yan; Wang, Qing; Chen, Yanming; Zhou, Honglong; Li, Zhi; Wang, Zhaotao*; Lan, Qing*; Wang, Yezhong*Oncogene, 2023, 42(14): 1088-1100.被引 4
